Authors:
Senst, BL
Achusim, LE
Genest, RP
Cosentino, LA
Ford, CC
Little, JA
Raybon, SJ
Bates, DW
Citation: Bl. Senst et al., Practical approach to determining costs and frequency of adverse drug events in a health care network, AM J HEAL S, 58(12), 2001, pp. 1126-1132
Authors:
Mandler, RN
Dencoff, JD
Midani, F
Ford, CC
Ahmed, W
Rosenberg, GA
Citation: Rn. Mandler et al., Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica, BRAIN, 124, 2001, pp. 493-498
Authors:
Johnson, KP
Brooks, BR
Ford, CC
Goodman, A
Guarnaccia, J
Lisak, RP
Myers, LW
Panitch, HS
Pruitt, A
Rose, JW
Kachuck, N
Wolinsky, JS
Citation: Kp. Johnson et al., Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years, MULT SCLER, 6(4), 2000, pp. 255-266
Citation: E. Ergene et al., Acute optic neuritis: Association with paranasal sinus inflammatory changes on magnetic resonance imaging, J NEUROIMAG, 10(4), 2000, pp. 209-215
Authors:
Perez-Mongiovi, D
Beckhelling, G
Chang, P
Ford, CC
Houliston, E
Citation: D. Perez-mongiovi et al., Nuclei and microtubule asters stimulate maturation/M phase promoting factor (MPF) activation in Xenopus eggs and egg cytoplasmic extracts, J CELL BIOL, 150(5), 2000, pp. 963-974
Authors:
Brooks, WM
Jung, RE
Ford, CC
Greinel, EJ
Sibbitt, WL
Citation: Wm. Brooks et al., Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus, J RHEUMATOL, 26(1), 1999, pp. 81-85
Authors:
Ford, CC
Brooks, BR
Johnson, KP
Lisak, RP
Myers, LW
Panitch, HS
Rose, JW
Schiffer, RB
Vollmer, T
Weiner, LP
Wolinsky, JS
Citation: Cc. Ford et al., Sustained efficacy of glatiramer acetate for injection in a 5+ year trial of relapsing remitting MS, MULT SCLER, 4(6), 1998, pp. 521-521